Table 3 The prevalence of MAFLD in individuals with different number of MS components
Number of MS risk components | Total population | Individuals with MAFLD | Prevalence (%) |
|---|---|---|---|
0 | 45,255 | 1471 | 3.3 |
1 | 36,339 | 5218 | 14.4 |
2 | 27,926 | 10,307 | 36.9 |
3 | 18,353 | 10,758 | 58.6 |
4 | 9033 | 6685 | 74.0 |
5 | 2264 | 1867 | 82.5 |